Special items: Ovarian Cancer and Us blog best viewed in Firefox

Saturday, September 03, 2016

Immunovaccine Announces Additional Positive Topline Results from Phase 1/1b Clinical Trial Program with DPX-Survivac in Ovarian Cancer

MedNews

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.